Secondary Antibody Deficiencies are defined by a decrease in antibodies that occur most commonly as a consequence of hematological malignancies, renal or gastrointestinal immunoglobulin loss, and corticosteroid, anticonvulsant or immunosuppressive medications. Immunoglobulin replacement therapy has been shown to be effective in reducing infections in some secondary antibody deficiencies. Initially, we hope to assist these patients, as the majority of primary immune deficiency patients receive immunoglobulin therapy.
These patients will include those with:
- Chronic Lymphocytic Leukaemia (CLL)
- Multiple Myeloma
- Non-Hodgkin Lymphoma
- Good’s syndrome
- Any Lymphomas or cancers of the lymph nodes or immune system
- Protein losing enteropathy (Gut)
- Lymphoreticular malignancy
- Antibody deficiency due to treatment for Autoimmune Disease using chemotherapy-like reagents (e.g.SLE)
There are similarities and cross over areas when living with an immune deficiency, whether it is primary or secondary. IDFA will be supplying our current resources that are relevant to your situation and age group. Have a browse through our resource page and you will see our range of resources. Once you join (membership and resources are free) you will be welcomed and a resource pack delivered to you. It will take some time for us to grow specific resources, however we will keep you informed!
Membership is available for:
· PATIENTS & CARERS: Complete the IDFA secondary immune deficiency membership form As there are sometimes more than one patient in each family, could you please complete a separate form for each patient?
- Complete the Family & Friends membership form
- Consider volunteering
- HEALTHCARE PROFESSIONALS membership form
- INDUSTRY & RELATED FIELDS membership form